Catecholaminergic Crisis After a Bleeding Complication of COVID-19 Infection: A Case Report.

No Thumbnail Available

Date

2021-09-08

Authors

Rebollo-Román, Angel
Alhambra-Expósito, Maria R
Herrera-Martínez, Yiraldine
Leiva-Cepas, F
Alzas, Carlos
Muñoz-Jiménez, Concepcion
Ortega-Salas, R
Molina-Puertas, María J
Gálvez-Moreno, Maria A
Herrera-Martínez, Aura D

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents in some cases with hemostatic and thrombotic complications. Pheochromocytomas are unusual, though potentially lethal tumors. Herein we describe the first case of hemorrhage in a pheochromocytoma related to SARS-CoV-2 infection. A 62-year-old man consulted for syncope, fever, and palpitations. He was diagnosed with SARS-CoV-2 pneumonia and presented with a hemorrhage in a previously unknown adrenal mass, which resulted in a catecholaminergic crisis. Medical treatment and surgery were required for symptom control and stabilization. We hereby alert clinicians to watch for additional/unreported clinical manifestations in COVID-19 infection.

Description

MeSH Terms

Adrenal Gland Neoplasms
COVID-19
Hemorrhage
Humans
Male
Middle Aged
Pheochromocytoma
Pneumonia

DeCS Terms

CIE Terms

Keywords

COVID19, bleeding, catecholamines, complication, pheochromocytoma

Citation